Released by Union minister Jitendra Singh, 'India Bioeconomy Report 2022' says country's biotech sector attained $80 billion in value in 2021, 14.1% growth over 2020.
Experts associated with IAAG have written to PM Modi claiming approvals for gene-edited plants have been ‘inordinately delayed’ as the regulatory body has sought opinion of states.
Moderna's shares, which nearly made an MIT professor a billionaire, began to slide after a report from the health publication Stat highlighted the early nature of the vaccine data.
As developments in technology and medicine race forward, our body data such as biomarkers and lifestyle logs could help accomplish advanced healthcare systems.
Dr Renu Swarup, secretary of the government’s Department of Biotechnology, talks about the state of Indian health technology and what the future holds.
Former Bangladesh Prime Minister Sheikh Hasina has, in a sense, tasted her own medicine. The International Crimes Tribunal, the special court she instituted for...
While global corporations setting up GCCs in India continue to express confidence in availability of skilled AI engineers, the panel argued that India’s real challenge lies elsewhere.
Without a Congress revival, there can be no challenge to the BJP pan-nationally. Modi’s party is growing, and almost entirely at the cost of the Congress.
COMMENTS